---
provider: falcon
model: Edison Scientific Literature
cached: false
start_time: '2025-12-27T02:34:08.978742'
end_time: '2025-12-27T02:40:08.589251'
duration_seconds: 359.61
template_file: templates/gene_research_go_focused.md
template_variables:
  organism: human
  gene_id: KCTD12
  gene_symbol: KCTD12
  uniprot_accession: Q96CX2
  protein_description: 'RecName: Full=BTB/POZ domain-containing protein KCTD12; AltName:
    Full=Pfetin; AltName: Full=Predominantly fetal expressed T1 domain;'
  gene_info: Name=KCTD12; Synonyms=C13orf2, KIAA1778, PFET1;
  organism_full: Homo sapiens (Human).
  protein_family: Not specified in UniProt
  protein_domains: BTB/POZ_dom. (IPR000210); H1_KCTD12. (IPR049905); SKP1/BTB/POZ_sf.
    (IPR011333); T1-type_BTB. (IPR003131); BTB_2 (PF02214)
provider_config:
  timeout: 600
  max_retries: 3
  parameters:
    allowed_domains: []
    temperature: 0.1
citation_count: 20
---

## Question

# Gene Research for Functional Annotation

## ⚠️ CRITICAL: Gene/Protein Identification Context

**BEFORE YOU BEGIN RESEARCH:** You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

### Target Gene/Protein Identity (from UniProt):
- **UniProt Accession:** Q96CX2
- **Protein Description:** RecName: Full=BTB/POZ domain-containing protein KCTD12; AltName: Full=Pfetin; AltName: Full=Predominantly fetal expressed T1 domain;
- **Gene Information:** Name=KCTD12; Synonyms=C13orf2, KIAA1778, PFET1;
- **Organism (full):** Homo sapiens (Human).
- **Protein Family:** Not specified in UniProt
- **Key Domains:** BTB/POZ_dom. (IPR000210); H1_KCTD12. (IPR049905); SKP1/BTB/POZ_sf. (IPR011333); T1-type_BTB. (IPR003131); BTB_2 (PF02214)

### MANDATORY VERIFICATION STEPS:

1. **Check if the gene symbol "KCTD12" matches the protein description above**
2. **Verify the organism is correct:** Homo sapiens (Human).
3. **Check if protein family/domains align with what you find in literature**
4. **If you find literature for a DIFFERENT gene with the same or similar symbol, STOP**

### If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

**DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.** Instead:
- State clearly: "The gene symbol 'KCTD12' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information

### Research Target:

Please provide a comprehensive research report on the gene **KCTD12** (gene ID: KCTD12, UniProt: Q96CX2) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

## Output

Question: You are an expert researcher providing comprehensive, well-cited information.

Provide detailed information focusing on:
1. Key concepts and definitions with current understanding
2. Recent developments and latest research (prioritize 2023-2024 sources)
3. Current applications and real-world implementations
4. Expert opinions and analysis from authoritative sources
5. Relevant statistics and data from recent studies

Format as a comprehensive research report with proper citations. Include URLs and publication dates where available.
Always prioritize recent, authoritative sources and provide specific citations for all major claims.

# Gene Research for Functional Annotation

## ⚠️ CRITICAL: Gene/Protein Identification Context

**BEFORE YOU BEGIN RESEARCH:** You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

### Target Gene/Protein Identity (from UniProt):
- **UniProt Accession:** Q96CX2
- **Protein Description:** RecName: Full=BTB/POZ domain-containing protein KCTD12; AltName: Full=Pfetin; AltName: Full=Predominantly fetal expressed T1 domain;
- **Gene Information:** Name=KCTD12; Synonyms=C13orf2, KIAA1778, PFET1;
- **Organism (full):** Homo sapiens (Human).
- **Protein Family:** Not specified in UniProt
- **Key Domains:** BTB/POZ_dom. (IPR000210); H1_KCTD12. (IPR049905); SKP1/BTB/POZ_sf. (IPR011333); T1-type_BTB. (IPR003131); BTB_2 (PF02214)

### MANDATORY VERIFICATION STEPS:

1. **Check if the gene symbol "KCTD12" matches the protein description above**
2. **Verify the organism is correct:** Homo sapiens (Human).
3. **Check if protein family/domains align with what you find in literature**
4. **If you find literature for a DIFFERENT gene with the same or similar symbol, STOP**

### If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

**DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.** Instead:
- State clearly: "The gene symbol 'KCTD12' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information

### Research Target:

Please provide a comprehensive research report on the gene **KCTD12** (gene ID: KCTD12, UniProt: Q96CX2) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Comprehensive research report: Human KCTD12 (UniProt: Q96CX2)

1) Identity, key concepts, and definitions
- Verified identity and nomenclature: KCTD12 (also known historically as Pfetin) is a human BTB/POZ- (T1-) domain-containing protein that functions as an auxiliary subunit of GABAB receptors (GBRs), shaping receptor signaling kinetics and desensitization via direct binding to the intracellular tail of GABAB2 and engagement with G-protein βγ subunits (reviewed 2024; Trends in Neurosciences, Aug 2024; https://doi.org/10.1016/j.tins.2024.05.008) (gonzalezhernandez2024emergingmodesof pages 5-7). Pan-cancer profiling in human tumors further frames KCTD12 in the GBR context, citing its role as an auxiliary component modulating GBR signaling and desensitization (Scientific Reports, Aug 2023; https://doi.org/10.1038/s41598-023-41091-8) (liu2023apancanceranalysis pages 6-9, liu2023apancanceranalysis pages 13-14).
- Domain architecture and assembly: KCTD family proteins share an N‑terminal BTB/POZ/T1 domain that mediates oligomerization and receptor binding; KCTD8/12/12b/16 directly bind the GABAB2 CTD via their T1 domains. KCTD12 operates in higher-order assemblies that are characteristically pentameric in the KCTD family; a pentameric KCTD12 complex binding the GBR is described in family-focused studies (Cells, May 2023; https://doi.org/10.3390/cells12091325; IJMS, Sep 2023; https://doi.org/10.3390/ijms241814317) (mansouri2023proteinnetworksassociated pages 8-10, liao2023kctd5formsheterooligomeric pages 9-10).

2) Mechanism, cellular localization, and pathways
- Biochemical mechanism at GABAB receptors: KCTD12 constitutively associates with the GABAB2 CTD and positions to rapidly engage Gβγ upon receptor activation, thereby accelerating activation and driving fast, Gβγ-targeted desensitization of GBR signaling. Reviews summarize that KCTD12 enhances desensitization kinetics, accelerates activation, and increases receptor surface levels (mechanisms partly unresolved) (Trends in Neurosciences, Aug 2024; https://doi.org/10.1016/j.tins.2024.05.008) (gonzalezhernandez2024emergingmodesof pages 5-7). Primary studies and curated analyses likewise note that KCTD12 “strongly desensitizes” GBR responses and co-purifies Gβγ even without GABAB2, consistent with direct Gβγ engagement (Cells, May 2023; https://doi.org/10.3390/cells12091325) (mansouri2023proteinnetworksassociated pages 8-10).
- Post-translational regulation affecting kinetics: In human cancer analyses collating GBR literature, KCTD12-dependent desensitization is reported to be modulated by phosphorylation of GABAB2 at S892 (PKA signaling), where KCTD12 binding promotes S892 phosphorylation and PKA-dependent conformational changes slow KCTD12-mediated desensitization (Scientific Reports, Aug 2023; https://doi.org/10.1038/s41598-023-41091-8) (liu2023apancanceranalysis pages 6-9).
- Cellular and subcellular localization: In mouse cerebellum, KCTD12 localizes with mGlu1α in the same peri/post-synaptic nanodomains of Purkinje cell spines by freeze-fracture replica immunogold EM, with nearest-neighbor distances indicating close spatial association but arguing against direct physical binding (spines: 26.70 ± 2.0 nm vs mGlu1α–mGlu1α 19.73 ± 0.85 nm; two-sample KS, p = 0.0028). Co-IP from tissue pulls down KCTD12 with mGlu1α, but recombinant co-expression fails to show direct binding; the association persists in GABAB KO tissue, consistent with an indirect linkage, potentially via G-proteins or other scaffold proteins (Cells, May 2023; https://doi.org/10.3390/cells12091325) (mansouri2023proteinnetworksassociated pages 10-13, mansouri2023proteinnetworksassociated pages 13-15).
- Network and pathway context: KCTDs are BTB/T1-domain proteins with frequent pentameric assemblies and broad GPCR regulatory roles. Family-level studies in 2024 demonstrate Cullin3- and Gβ-dependent mechanisms for KCTDs (notably KCTD5) in regulating adenylyl cyclase sensitization and opioid dependence; these data underscore conserved KCTD–Gβ interactions relevant to GBR/KCTD12 signaling but are not direct KCTD12-specific findings (PLOS Biology, Jul 2024; https://doi.org/10.1371/journal.pbio.3002716) (ding2024kctdproteinsregulate pages 10-15).

3) Recent developments (2023–2024)
- GABAB–KCTD12 mechanistic updates: Authoritative review synthesis in 2024 emphasizes constitutive KCTD–GABAB2 CTD binding, Gβγ-targeted desensitization by KCTD12, and effects on activation kinetics and surface expression (Trends in Neurosciences, Aug 2024; https://doi.org/10.1016/j.tins.2024.05.008) (gonzalezhernandez2024emergingmodesof pages 5-7).
- Cross-receptor proximity: A 2023 cerebellar interactome and ultrastructural study identifies KCTD12 in mGlu1α-associated protein clusters and nanodomains in vivo, but indicates the interaction is indirect and independent of GABAB receptors (Cells, May 2023; https://doi.org/10.3390/cells12091325) (mansouri2023proteinnetworksassociated pages 10-13, mansouri2023proteinnetworksassociated pages 13-15, mansouri2023proteinnetworksassociated pages 8-10).
- Cancer-focused integrative analysis: Pan-cancer profiling in 2023 integrates KCTD12 biology with tumor genomics, immune infiltration, and stemness, while also consolidating GBR regulatory concepts including KCTD12-driven desensitization and S892-dependent modulation (Scientific Reports, Aug 2023; https://doi.org/10.1038/s41598-023-41091-8) (liu2023apancanceranalysis pages 6-9, liu2023apancanceranalysis pages 13-14).

4) Current applications and real-world implementations
- Pfetin (KCTD12) as a clinical biomarker in GIST: Pan-cancer analysis reiterates KCTD12/Pfetin as a GIST-specific biomarker with prognostic utility for recurrence based on prior clinical literature; it highlights immunohistochemistry-based detection and diagnostic potential (Scientific Reports, Aug 2023; https://doi.org/10.1038/s41598-023-41091-8) (liu2023apancanceranalysis pages 6-9). While the integrative paper cites this application, it aggregates prior clinical studies rather than providing new prospective validation. 
- Broader oncology utility: The same study suggests diagnostic sensitivity across tumor types and correlations with tumor microenvironment features, implying potential for risk stratification or companion biomarker roles pending disease- and context-specific validation (Scientific Reports, Aug 2023; https://doi.org/10.1038/s41598-023-41091-8) (liu2023apancanceranalysis pages 6-9, liu2023apancanceranalysis pages 13-14).

5) Expert opinions and authoritative commentary
- A 2024 Trends in Neurosciences review frames KCTD12 as a prototypical GBR auxiliary subunit that binds GABAB2 CTD and targets Gβγ to confer rapid desensitization, with added effects on activation and receptor trafficking; it emphasizes that mechanisms for surface level increases remain incompletely defined (Trends in Neurosciences, Aug 2024; https://doi.org/10.1016/j.tins.2024.05.008) (gonzalezhernandez2024emergingmodesof pages 5-7).
- Family-level insights: Contemporary work on KCTDs and Cullin3-centric complexes (though focused on other KCTDs) underscore BTB/T1-driven assemblies and Gβ-centric signaling control as a common architectural theme, aligning with KCTD12’s GBR functions (PLOS Biology, Jul 2024; https://doi.org/10.1371/journal.pbio.3002716) (ding2024kctdproteinsregulate pages 10-15).

6) Quantitative data and statistics from recent studies
- mGlu1–KCTD12 nanoscale organization in cerebellar Purkinje cells: nearest-neighbor analysis showed mGlu1α–KCTD12 mean distances 26.70 ± 2.0 nm (spines) and 36.86 ± 3.44 nm (dendrites), significantly larger than mGlu1α–mGlu1α distances (19.73 ± 0.85 nm; 22.90 ± 0.95 nm), arguing against direct binding (KS tests spines p = 0.0028; dendrites p = 0.0001) (Cells, May 2023; https://doi.org/10.3390/cells12091325) (mansouri2023proteinnetworksassociated pages 10-13, mansouri2023proteinnetworksassociated pages 13-15).
- Pan-cancer transcriptome and proteome statistics: KCTD12 co-expression included CSF1R (R = 0.64, P < 0.001) and DCHS1 (R = 0.53, P < 0.001); stemness correlations example values: THYM R = 0.3638 (P = 4.75E-05), GBM R = -0.5566 (P = 2.22E-05), TGCT R = -0.6045 (P = 5.19E-16), BLCA R = -0.3408 (P = 2.05E-12). Immune infiltration correlations with CAFs and T cells were evaluated across multiple algorithms (EPIC, MCP-COUNTER, XCELL, TIDE); the study details significant associations in specific cancers (Scientific Reports, Aug 2023; https://doi.org/10.1038/s41598-023-41091-8) (liu2023apancanceranalysis pages 6-9, liu2023apancanceranalysis pages 13-14).

7) Clarifications on Cullin3/E3 ligase questions for KCTD12
- While multiple KCTD proteins recruit Cullin3 via BTB domains to form CRL3 E3 ligases, direct Cul3 engagement is strongly supported for certain family members (e.g., KCTD5), with family-level opioid signaling work showing KCTD–Gβ interactions and Cul3 dependence. The 2023–2024 evidence compiled here does not provide direct biochemical proof that KCTD12 forms a functional CRL3 with Cul3; by contrast, KCTD12’s best-established role remains its GBR auxiliary subunit function via GABAB2 CTD and Gβγ interactions (PLOS Biology, Jul 2024; https://doi.org/10.1371/journal.pbio.3002716; Trends in Neurosciences, Aug 2024; https://doi.org/10.1016/j.tins.2024.05.008; Cells, May 2023; https://doi.org/10.3390/cells12091325) (ding2024kctdproteinsregulate pages 10-15, gonzalezhernandez2024emergingmodesof pages 5-7, mansouri2023proteinnetworksassociated pages 8-10).

8) Synthesis and functional annotation
- Primary function: KCTD12 is a non-enzymatic scaffold/auxiliary subunit that directly binds the GABAB2 C-terminus and Gβγ to sculpt GBR signaling—accelerating activation, promoting rapid Gβγ-targeted desensitization, and influencing receptor surface expression (Trends in Neurosciences, Aug 2024; https://doi.org/10.1016/j.tins.2024.05.008; Cells, May 2023; https://doi.org/10.3390/cells12091325) (gonzalezhernandez2024emergingmodesof pages 5-7, mansouri2023proteinnetworksassociated pages 8-10).
- Site of action: Predominantly at neuronal synapses where GABAB receptors operate; in the cerebellum, KCTD12 resides in postsynaptic nanodomains of Purkinje cell spines and dendrites, and can be found in mGlu1α-containing clusters via indirect associations (Cells, May 2023; https://doi.org/10.3390/cells12091325) (mansouri2023proteinnetworksassociated pages 10-13, mansouri2023proteinnetworksassociated pages 13-15).
- Broader relevance: Systems-level analyses tie KCTD12 expression to tumor biology and immune/stemness features; clinically, KCTD12/Pfetin has been repeatedly reported as a GIST prognostic biomarker (Scientific Reports, Aug 2023; https://doi.org/10.1038/s41598-023-41091-8) (liu2023apancanceranalysis pages 6-9, liu2023apancanceranalysis pages 13-14).

Limitations of current evidence in this synthesis
- Direct human structural data for KCTD12 pentamers and Cul3 recruitment are not included in the cited 2023–2024 sources compiled here; pentameric assembly is supported by family-level literature and specific statements referencing KCTD12 complexes (IJMS, Sep 2023; https://doi.org/10.3390/ijms241814317) (liao2023kctd5formsheterooligomeric pages 9-10). The cerebellar mGlu1α association appears indirect and requires further molecular dissection (mansouri2023proteinnetworksassociated pages 10-13, mansouri2023proteinnetworksassociated pages 13-15).

References (with URLs and dates)
- Gonzalez-Hernandez AJ, Munguba H, Levitz J. Emerging modes of regulation of neuromodulatory G protein-coupled receptors. Trends in Neurosciences. Aug 2024. https://doi.org/10.1016/j.tins.2024.05.008 (gonzalezhernandez2024emergingmodesof pages 5-7)
- Mansouri M et al. Protein Networks Associated with Native Metabotropic Glutamate 1 Receptors (mGlu1) in the Mouse Cerebellum. Cells. May 2023. https://doi.org/10.3390/cells12091325 (mansouri2023proteinnetworksassociated pages 10-13, mansouri2023proteinnetworksassociated pages 13-15, mansouri2023proteinnetworksassociated pages 8-10)
- Liu P et al. A pan-cancer analysis of potassium channel tetramerization domain containing 12 in human cancer. Scientific Reports. Aug 2023. https://doi.org/10.1038/s41598-023-41091-8 (liu2023apancanceranalysis pages 6-9, liu2023apancanceranalysis pages 13-14)
- Liao Y et al. KCTD5 Forms Hetero-Oligomeric Complexes with Various Members of the KCTD Protein Family. International Journal of Molecular Sciences. Sep 2023. https://doi.org/10.3390/ijms241814317 (liao2023kctd5formsheterooligomeric pages 9-10)
- Ding Z et al. KCTD proteins regulate morphine dependence via heterologous sensitization of adenylyl cyclase 1 in mice. PLOS Biology. Jul 2024. https://doi.org/10.1371/journal.pbio.3002716 (ding2024kctdproteinsregulate pages 10-15)

References

1. (gonzalezhernandez2024emergingmodesof pages 5-7): Alberto J. Gonzalez-Hernandez, Hermany Munguba, and Joshua Levitz. Emerging modes of regulation of neuromodulatory g protein-coupled receptors. Trends in Neurosciences, 47:635-650, Aug 2024. URL: https://doi.org/10.1016/j.tins.2024.05.008, doi:10.1016/j.tins.2024.05.008. This article has 23 citations and is from a highest quality peer-reviewed journal.

2. (liu2023apancanceranalysis pages 6-9): Pan Liu, Zhilan Liu, Qiankun Luo, Qiang Fu, Xu Zhang, Pengfei Yu, Shuai Zhou, Yingying Wang, Jiali Zhang, Song Chen, Hongwei Zhang, Qinghai Zhu, and Tao Qin. A pan-cancer analysis of potassium channel tetramerization domain containing 12 in human cancer. Scientific Reports, Aug 2023. URL: https://doi.org/10.1038/s41598-023-41091-8, doi:10.1038/s41598-023-41091-8. This article has 6 citations and is from a peer-reviewed journal.

3. (liu2023apancanceranalysis pages 13-14): Pan Liu, Zhilan Liu, Qiankun Luo, Qiang Fu, Xu Zhang, Pengfei Yu, Shuai Zhou, Yingying Wang, Jiali Zhang, Song Chen, Hongwei Zhang, Qinghai Zhu, and Tao Qin. A pan-cancer analysis of potassium channel tetramerization domain containing 12 in human cancer. Scientific Reports, Aug 2023. URL: https://doi.org/10.1038/s41598-023-41091-8, doi:10.1038/s41598-023-41091-8. This article has 6 citations and is from a peer-reviewed journal.

4. (mansouri2023proteinnetworksassociated pages 8-10): Mahnaz Mansouri, Leopold Kremser, Thanh-Phuong Nguyen, Yu Kasugai, Laura Caberlotto, Martin Gassmann, Bettina Sarg, Herbert Lindner, Bernhard Bettler, Lucia Carboni, and Francesco Ferraguti. Protein networks associated with native metabotropic glutamate 1 receptors (mglu1) in the mouse cerebellum. Cells, 12:1325, May 2023. URL: https://doi.org/10.3390/cells12091325, doi:10.3390/cells12091325. This article has 2 citations and is from a poor quality or predatory journal.

5. (liao2023kctd5formsheterooligomeric pages 9-10): Yini Liao, Douglas C. Sloan, Josephine H. Widjaja, and Brian S. Muntean. Kctd5 forms hetero-oligomeric complexes with various members of the kctd protein family. International Journal of Molecular Sciences, 24:14317, Sep 2023. URL: https://doi.org/10.3390/ijms241814317, doi:10.3390/ijms241814317. This article has 9 citations and is from a poor quality or predatory journal.

6. (mansouri2023proteinnetworksassociated pages 10-13): Mahnaz Mansouri, Leopold Kremser, Thanh-Phuong Nguyen, Yu Kasugai, Laura Caberlotto, Martin Gassmann, Bettina Sarg, Herbert Lindner, Bernhard Bettler, Lucia Carboni, and Francesco Ferraguti. Protein networks associated with native metabotropic glutamate 1 receptors (mglu1) in the mouse cerebellum. Cells, 12:1325, May 2023. URL: https://doi.org/10.3390/cells12091325, doi:10.3390/cells12091325. This article has 2 citations and is from a poor quality or predatory journal.

7. (mansouri2023proteinnetworksassociated pages 13-15): Mahnaz Mansouri, Leopold Kremser, Thanh-Phuong Nguyen, Yu Kasugai, Laura Caberlotto, Martin Gassmann, Bettina Sarg, Herbert Lindner, Bernhard Bettler, Lucia Carboni, and Francesco Ferraguti. Protein networks associated with native metabotropic glutamate 1 receptors (mglu1) in the mouse cerebellum. Cells, 12:1325, May 2023. URL: https://doi.org/10.3390/cells12091325, doi:10.3390/cells12091325. This article has 2 citations and is from a poor quality or predatory journal.

8. (ding2024kctdproteinsregulate pages 10-15): Zhong Ding, Chunsheng Zhang, Huicui Yang, Jiaojiao Chen, Zhiruo Sun, and Xuechu Zhen. Kctd proteins regulate morphine dependence via heterologous sensitization of adenylyl cyclase 1 in mice. PLOS Biology, 22:e3002716, Jul 2024. URL: https://doi.org/10.1371/journal.pbio.3002716, doi:10.1371/journal.pbio.3002716. This article has 3 citations and is from a highest quality peer-reviewed journal.

## Citations

1. gonzalezhernandez2024emergingmodesof pages 5-7
2. mansouri2023proteinnetworksassociated pages 8-10
3. liu2023apancanceranalysis pages 6-9
4. ding2024kctdproteinsregulate pages 10-15
5. liu2023apancanceranalysis pages 13-14
6. mansouri2023proteinnetworksassociated pages 10-13
7. mansouri2023proteinnetworksassociated pages 13-15
8. https://doi.org/10.1016/j.tins.2024.05.008
9. https://doi.org/10.1038/s41598-023-41091-8
10. https://doi.org/10.3390/cells12091325;
11. https://doi.org/10.3390/ijms241814317
12. https://doi.org/10.3390/cells12091325
13. https://doi.org/10.1371/journal.pbio.3002716
14. https://doi.org/10.1371/journal.pbio.3002716;
15. https://doi.org/10.1016/j.tins.2024.05.008;
16. https://doi.org/10.1016/j.tins.2024.05.008,
17. https://doi.org/10.1038/s41598-023-41091-8,
18. https://doi.org/10.3390/cells12091325,
19. https://doi.org/10.3390/ijms241814317,
20. https://doi.org/10.1371/journal.pbio.3002716,